Head-To-Head Analysis: ClearPoint Neuro (NASDAQ:CLPT) and Bionik Laboratories (OTCMKTS:BNKL)

ClearPoint Neuro (NASDAQ:CLPT) and Bionik Laboratories (OTCMKTS:BNKL) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, institutional ownership, analyst recommendations and profitability.

Volatility & Risk

ClearPoint Neuro has a beta of 0.91, suggesting that its share price is 9% less volatile than the S&P 500. Comparatively, Bionik Laboratories has a beta of -1.69, suggesting that its share price is 269% less volatile than the S&P 500.

Insider & Institutional Ownership

30.1% of ClearPoint Neuro shares are owned by institutional investors. 7.0% of ClearPoint Neuro shares are owned by insiders. Comparatively, 34.7% of Bionik Laboratories shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for ClearPoint Neuro and Bionik Laboratories, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ClearPoint Neuro	1	0	3	0	2.50
Bionik Laboratories	0	0	0	0	0.00

ClearPoint Neuro presently has a consensus target price of $19.67, indicating a potential upside of 27.62%. Given ClearPoint Neuro’s stronger consensus rating and higher probable upside, equities research analysts clearly believe ClearPoint Neuro is more favorable than Bionik Laboratories.

Profitability

This table compares ClearPoint Neuro and Bionik Laboratories’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ClearPoint Neuro	-67.40%	-114.28%	-48.09%
Bionik Laboratories	N/A	N/A	N/A

Earnings & Valuation

This table compares ClearPoint Neuro and Bionik Laboratories”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ClearPoint Neuro	$31.39 million	13.95	-$18.91 million	($0.84)	-18.35
Bionik Laboratories	$1.80 million	N/A	-$4.95 million	($0.38)	N/A

Bionik Laboratories has lower revenue, but higher earnings than ClearPoint Neuro. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Bionik Laboratories, indicating that it is currently the more affordable of the two stocks.

About ClearPoint Neuro

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

About Bionik Laboratories

Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; InMotion ARM/HAND, which provides support for therapy involving reaching with grasp and release movements, and individual hand movements; and InMotion Connect platform that consists of a hardware device connected to the InMotion Robot, as well as a subscription to InMotion Connect Pulse. Bionik Laboratories Corp. was incorporated in 2010 and is headquartered in Watertown, Massachusetts.